Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
Debt to Equity Over TimeFair Value
Percentile Rank57
3Y CAGR+2.2%
5Y CAGR-6.4%
Year-over-Year Change
Debt-to-equity ratio
3Y CAGR
+2.2%/yr
vs -31.5%/yr prior
5Y CAGR
-6.4%/yr
Recent acceleration
Acceleration
+33.7pp
Accelerating
Percentile
P57
Within normal range
vs 5Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive growthFair Value
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 0.05 | +74.9% |
| 2024 | 0.03 | -56.1% |
| 2023 | 0.07 | +39.2% |
| 2022 | 0.05 | -47.7% |
| 2021 | 0.09 | +28.2% |
| 2020 | 0.07 | +152.0% |
| 2019 | -0.14 | -163.2% |
| 2018 | 0.22 | -13.5% |
| 2017 | 0.26 | +767.2% |
| 2016 | 0.03 | - |